US Patent Issued to Deerland Enzymes on Dec. 9 for "Prebiotic bacteriophage containing composition for treatment of gastrointestinal inflammation" (Georgia Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,215, issued on Dec. 9, was assigned to Deerland Enzymes Inc. (Kennesaw, Ga.).

"Prebiotic bacteriophage containing composition for treatment of gastrointestinal inflammation" was invented by John Deaton (Kennesaw, Ga.) and Ana Maria Cuentas (Woodstock, Ga.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides a method of treating gastrointestinal inflammation such as inflammatory bowel disease (IBS) with a bacteriophage containing composition. The bacteriophage containing composition can be used as prebiotic supplementation and support of the gastrointestinal microflora. This disclosure relates to compositions that comprise one or mo...